Protein kinase CK2 inhibition induces cell death via early impact on mitochondrial function

Fatima Qaiser1, Janeen H Trembley, Betsy T Kren

  • 1Cellular and Molecular Biochemistry Research Laboratory (151), Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota, 55417; Department of Laboratory Medicine and Pathology, University of Minnesota School of Medicine, Minneapolis, MN, 55455; Department of Biochemistry and Molecular Biology, Army Medical College, National University of Sciences and Technology, Islamabad, Pakistan.

Insights

Casein kinase 2 (CK2) inhibition triggers cell death by rapidly decreasing mitochondrial membrane potential (Δψm). This early Δψm loss, potentially mediated by mitochondrial CK2, precedes other apoptotic signals, suggesting a key role in cell death induction.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Casein kinase 2 (CK2) is a critical regulator of apoptosis, suppressing cell death.
  • CK2 downregulation or inhibition potently induces apoptosis.
  • The precise mechanisms by which CK2 impacts mitochondrial apoptotic pathways are not fully understood.

Purpose of the Study:

  • To elucidate the early molecular events following CK2 inhibition that lead to cell death.
  • To investigate the role of mitochondrial membrane potential (Δψm) in CK2-mediated apoptosis.
  • To determine if mitochondrial-localized CK2 is involved in regulating Δψm.

Main Methods:

  • Utilized prostate cancer cell lines treated with CK2-specific inhibitors (TBB, TBCA).
  • Monitored mitochondrial membrane potential (Δψm) using established assays.
  • Investigated the presence and localization of CK2 within purified mitochondria.
  • Assessed alterations in calcium (Ca2+) signaling.

Main Results:

  • CK2 inhibition rapidly decreased Δψm within 2 hours in prostate cancer cells.
  • This Δψm loss occurred significantly before other mitochondrial apoptotic signals.
  • CK2 was detected in purified mitochondria, suggesting a role for mitochondrial CK2.
  • Evidence suggests Ca2+ signaling alterations may be involved in regulating Δψm.

Conclusions:

  • Early loss of Δψm is a primary mechanism by which CK2 inhibition induces apoptosis.
  • Mitochondrial-localized CK2 likely plays a role in regulating Δψm.
  • CK2 inhibition triggers cell death through early disruption of mitochondrial function, potentially involving Ca2+ signaling.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K